inds
Entity, reached from Hormuz.
- Evidence
- 35 documents · 3 separate publishers
- Standing
- Added automatically from coverage
- Time
- first seen 12 Apr 2026, last seen 9 Oct 2026
- Measured
- 46% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- FDA · 2026-10-09 · Phase 1 IND Frequently Asked Questions (opens the source in a new tab)
- The Clinical Trial Vanguard · 2026-10-03 · DHHS Releases 2026 Unified Agenda With Five Clinical Research Rule Changes (opens the source in a new tab)
- FDA · 2026-09-17 · Investigational New Drug Application (IND) (opens the source in a new tab)
- FDA · 2026-09-04 · Phase 1 IND Chemistry, Manufacturing, and Controls Flexibilities (opens the source in a new tab)
- FDA Drug News · 2026-07-08 · Guidance Recap Podcast | Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations (opens the source in a new tab)
- FDA Drug News · 2026-06-22 · Phase 1 IND Federal Regulations (opens the source in a new tab)
- FDA Drug News · 2026-06-18 · Investigational New Drug (IND) Application (opens the source in a new tab)
- FDA Drug News · 2026-05-20 · Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations (opens the source in a new tab)
- FDA Drug News · 2026-04-12 · Bioanalytical Method Validation for Biomarkers (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with fda (30 documents)seen together
- co-mentioned with drug administration (16 documents)seen together
- co-mentioned with investigational new drug (15 documents)seen together
- co-mentioned with adverse events (15 documents)seen together
- co-mentioned with cder (12 documents)seen together
- co-mentioned with medwatch (12 documents)seen together
- co-mentioned with reporting system (12 documents)seen together
- co-mentioned with clinical trials (9 documents)seen together
- co-mentioned with oncology center (9 documents)seen together